You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 264 No. 20, November 28, 1990 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prospective Study of Estrogen Replacement Therapy and Risk of Breast Cancer in Postmenopausal Women

Graham A. Colditz, MB, BS; Meir J. Stampfer, MD; Walter C. Willett, MD; Charles H. Hennekens, MD; Bernard Rosner, PhD; Frank E. Speizer, MD

JAMA. 1990;264(20):2648-2653.


Abstract

We prospectively examined the use of estrogen replacement therapy in relation to breast cancer incidence in a cohort of women 30 to 55 years of age in 1976. During 367 187 person-years of follow-up among postmenopausal women, 722 incident cases of breast cancer were documented. Overall, past users of replacement estrogen were not at increased risk (relative risk, 0.98; 95% confidence interval, 0.81 to 1.18), including even those with more than 10 years of use (relative risk after adjustment for established risk factors, 0.70; 95% confidence interval, 0.45 to 1.10). However, the risk of breast cancer was significantly elevated among current users (relative risk, 1.36; 95% confidence interval, 1.11 to 1.67). Among current users, a stronger relationship was observed with increasing age but not with increasing duration of use. These data suggest that long-term past use of estrogen replacement therapy is not related to risk of breast cancer but that current use may modestly increase risk.

(JAMA. 1990;264:2648-2653)



Author Affiliations

From the Channing Laboratory, Department of Medicine, Brigham and Women's Hospital (Drs Colditz, Stampfer, Willett, and Speizer), the Department of Medicine and Preventive Medicine, Harvard Medical School (Drs Hennekens and Rosner), and the Departments of Epidemiology (Drs Stampfer and Willett) and Nutrition (Dr Willett), Harvard School of Public Health, Boston, Mass.


Footnotes

Reprint requests to Channing Laboratory, 180 Longwood Ave, Boston, MA 02115-5899(Dr Colditz).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Alcohol Consumption and Breast Cancer Risk in the Women's Health Study
Zhang et al.
Am J Epidemiol 2007;165:667-676.
ABSTRACT | FULL TEXT  

Menopausal hormone therapy and risk of breast cancer: a meta-analysis of epidemiological studies and randomized controlled trials
Greiser et al.
Hum Reprod Update 2005;11:561-573.
ABSTRACT | FULL TEXT  

Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI rats
Li et al.
Proc. Natl. Acad. Sci. USA 2004;101:18123-18128.
ABSTRACT | FULL TEXT  

Use of Oral Contraceptives, Alcohol, and Risk for Invasive Breast Cancer
Dumeaux et al.
Cancer Epidemiol. Biomarkers Prev. 2004;13:1302-1307.
ABSTRACT | FULL TEXT  

Comprehensive Evaluation of the Older Woman
Amin et al.
Mayo Clin Proc. 2003;78:1157-1185.
ABSTRACT  

Relationship Between Long Durations and Different Regimens of Hormone Therapy and Risk of Breast Cancer
Li et al.
JAMA 2003;289:3254-3263.
ABSTRACT | FULL TEXT  

Use of Postmenopausal Hormones, Alcohol, and Risk for Invasive Breast Cancer
Chen et al.
ANN INTERN MED 2002;137:798-804.
ABSTRACT | FULL TEXT  

Beneficial Effects of Soybean Isoflavone Supplementation on Bone Metabolism and Serum Lipids in Postmenopausal Japanese Women: A Four-Week Study
Uesugi et al.
J. Am. Coll. Nutr. 2002;21:97-102.
ABSTRACT | FULL TEXT  

Alcohol and Breast Cancer: Review of Epidemiologic and Experimental Evidence and Potential Mechanisms
Singletary and Gapstur
JAMA 2001;286:2143-2151.
ABSTRACT | FULL TEXT  

Postmenopausal hormones and heart disease
Grady and Hulley
J Am Coll Cardiol 2001;38:8-10.
FULL TEXT  

Indicators of Lifetime Estrogen Exposure: Effect on Breast Cancer Incidence and Interaction With Raloxifene Therapy in the Multiple Outcomes of Raloxifene Evaluation Study Participants
Lippman et al.
JCO 2001;19:3111-3116.
ABSTRACT | FULL TEXT  

Risk of breast cancer associated with hormone replacement therapy
Dopp and Kolesar
J Oncol Pharm Pract 1999;5:109-116.
ABSTRACT  

Postmenopausal Hormone Replacement Therapy: Effect on Diagnosis and Outcome in Early-Stage Invasive Breast Cancer Treated With Conservative Surgery and Radiation
Fowble et al.
JCO 1999;17:1680-1680.
ABSTRACT | FULL TEXT  

The Efficacy of Hormonal Therapy for Reducing Coronary Artery Disease in Women
Merz
J. Clin. Endocrinol. Metab. 1999;84:1810-1812.
FULL TEXT  

Hormone Replacement Therapy and High S Phase in Breast Cancer
Cobleigh et al.
JAMA 1999;281:1528-1530.
ABSTRACT | FULL TEXT  

Relationship between Serum Estradiol Levels and the Increases in High-Density Lipoprotein Levels in Postmenopausal Women Treated with Oral Estradiol
Walsh et al.
J. Clin. Endocrinol. Metab. 1999;84:985-989.
ABSTRACT | FULL TEXT  

Estrogen Replacement Therapy and Breast Cancer Survival in a Large Screening Study
Schairer et al.
JNCI J Natl Cancer Inst 1999;91:264-270.
ABSTRACT | FULL TEXT  

Combined Hormone Replacement Therapy Does Not Protect Women Against the Age-Related Decline in Endothelium-Dependent Vasomotor Function
Sorensen et al.
Circulation 1998;97:1234-1238.
ABSTRACT | FULL TEXT  

Estrogen Sulfotransferase Expression in the Human Liver: Marked Interindividual Variation and Lack of Gender Specificity
Song et al.
J. Pharmacol. Exp. Ther. 1998;284:1197-1202.
ABSTRACT | FULL TEXT  

Weight and Risk for Breast Cancer
Kelsey and Baron
JAMA 1997;278:1448-1449.
ABSTRACT  

The Critical Role of Alcohol Consumption in Determining the Risk of Breast Cancer with Postmenopausal Estrogen Administration
Zumoff
J. Clin. Endocrinol. Metab. 1997;82:1656-1658.
FULL TEXT  

Effects of Alcohol Ingestion on Estrogens in Postmenopausal Women
Ginsburg et al.
JAMA 1996;276:1747-1751.
ABSTRACT  

Postmenopausal Estrogens and Breast Cancer
Colditz
Reproductive Sciences 1996;3:50-56.
 

Breast Cancer and Hormone-Replacement Therapy
Brunoski et al.
NEJM 1995;333:1355-1358.
FULL TEXT  

Organochlorine Residues and Risk of Breast Cancer
Houghton and Ritter
International Journal of Toxicology 1995;14:71-89.
ABSTRACT  

Estrogen Replacement Therapy in Breast Cancer Survivors
Atkins
JAMA 1995;273:619-619.
ABSTRACT  

Estrogen Replacement Therapy in Breast Cancer Survivors: A Time for Change
Cobleigh et al.
JAMA 1994;272:540-545.
ABSTRACT  

Hormone replacement therapy Cardioprotective effect is genuine
Duncan et al.
BMJ 1994;309:191-192.
FULL TEXT  

Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased?
Potshuma et al.
BMJ 1994;308:1268-1269.
ABSTRACT | FULL TEXT  

Hormonal Treatment of Postmenopausal Women
Belchetz
NEJM 1994;330:1062-1071.
FULL TEXT  

Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
Grady et al.
ANN INTERN MED 1992;117:1016-1037.
ABSTRACT  

The Postmenopausal Estrogen/Breast Cancer Controversy
Henrich
JAMA 1992;268:1900-1902.
ABSTRACT  

Endocrinology
Loriaux
JAMA 1992;268:352-354.
ABSTRACT  

Estrogen Replacement Therapy and Risk of Breast Cancer: Results of Two Meta-analyses-Reply
Dupont and Page
Arch Intern Med 1992;152:1090-1093.
ABSTRACT  

Estrogen Replacement Therapy and Risk of Breast Cancer
Bush and Helzlsouer
JAMA 1991;266:1357-1357.
ABSTRACT  

Estrogen Replacement Therapy and Risk of Breast Cancer
Dupont
JAMA 1991;265:1824-1824.
ABSTRACT  

Estrogen Replacement Therapy and Risk of Breast Cancer
Pike et al.
JAMA 1991;265:1824-1824.
ABSTRACT  

Estrogen Replacement Therapy and Risk of Breast Cancer
Vatz and Kellie
JAMA 1991;265:1824-1825.
ABSTRACT  

POSTMENOPAUSAL ESTROGEN USE MAY PROMOTE BREAST CANCER
JWatch General 1990;1990:2-2.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.